UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more
UMediC Group Berhad (0256) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: -0.034x
Based on the latest financial reports, UMediC Group Berhad (0256) has a cash flow conversion efficiency ratio of -0.034x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-2.80 Million) by net assets (RM83.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
UMediC Group Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
UMediC Group Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UMediC Group Berhad ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pool Advista Indonesia Tbk
JK:POOL
|
0.022x |
|
Curative Biotechnology Inc
NYSE MKT:CUBT
|
0.037x |
|
Indomobil Multi Jasa Tbk
JK:IMJS
|
0.089x |
|
Electro-Sensors Inc
NASDAQ:ELSE
|
0.027x |
|
ADVFN Plc
PINK:AVFCF
|
-0.118x |
|
NeuroMetrix Inc
NASDAQ:NURO
|
-0.132x |
|
IERVOLINO ENTERTAINMENT
F:G37
|
N/A |
|
Thai Nam Plastic Public Company Limited
BK:TNPC
|
-0.002x |
Annual Cash Flow Conversion Efficiency for UMediC Group Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of UMediC Group Berhad from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | RM81.35 Million | RM11.18 Million | 0.137x | +131.41% |
| 2024-07-31 | RM72.77 Million | RM4.32 Million | 0.059x | +109.05% |
| 2023-07-31 | RM63.48 Million | RM1.80 Million | 0.028x | -82.34% |
| 2022-07-31 | RM52.68 Million | RM8.48 Million | 0.161x | -30.61% |
| 2021-07-31 | RM15.74 Million | RM3.65 Million | 0.232x | +139.33% |
| 2020-07-31 | RM6.63 Million | RM-3.91 Million | -0.590x | -- |